Un programma basato sul Web per aiutare gli operatori sanitari dei pazienti polmonari a conoscere le risorse di terapia di supporto disponibili (CONNECT)
Pianificazione oncologica comunitaria multisito per l'intervento CONNECT rivolto agli operatori sanitari affetti da cancro al polmone
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.
Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.
Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:
- Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
- Group 2 will be provided with a generic supportive care resource list.
- Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.
Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80205
- Kaiser Permanente-Franklin
-
Lafayette, Colorado, Stati Uniti, 80026
- Kaiser Permanente - Rock Creek
-
Lone Tree, Colorado, Stati Uniti, 80124
- Kaiser Permanente - Lone Tree
-
-
Delaware
-
Millville, Delaware, Stati Uniti, 19967
- Beebe South Coastal Health Campus
-
Rehoboth Beach, Delaware, Stati Uniti, 19971
- Beebe Health Campus
-
-
Georgia
-
Augusta, Georgia, Stati Uniti, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
‘Aiea, Hawaii, Stati Uniti, 96701
- Hawaii Cancer Care - Westridge
-
-
Missouri
-
Osage Beach, Missouri, Stati Uniti, 65065
- Lake Regional Hospital
-
Springfield, Missouri, Stati Uniti, 65807
- CoxHealth South Hospital
-
-
New York
-
The Bronx, New York, Stati Uniti, 10461
- Montefiore Medical Center-Einstein Campus
-
-
North Carolina
-
Winston-Salem, North Carolina, Stati Uniti, 27157
- Wake Forest NCORP Research Base
-
-
Pennsylvania
-
Scranton, Pennsylvania, Stati Uniti, 18510
- Community Medical Center
-
Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
South Carolina
-
Gaffney, South Carolina, Stati Uniti, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Stati Uniti, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Stati Uniti, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Stati Uniti, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Stati Uniti, 29303
- Spartanburg Medical Center
-
Union, South Carolina, Stati Uniti, 29379
- MGC Hematology Oncology-Union
-
-
Wisconsin
-
Appleton, Wisconsin, Stati Uniti, 54911
- ThedaCare Regional Cancer Center
-
Green Bay, Wisconsin, Stati Uniti, 54311
- Aurora BayCare Medical Center
-
Kenosha, Wisconsin, Stati Uniti, 53142
- Aurora Cancer Care-Kenosha South
-
Milwaukee, Wisconsin, Stati Uniti, 53215
- Aurora Saint Luke's Medical Center
-
Neenah, Wisconsin, Stati Uniti, 54956
- ThedaCare Regional Medical Center - Neenah
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Patient Inclusion Criteria:
- Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
- Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
- Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
- Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate
Caregiver Inclusion Criteria:
- Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
- Must have access to the internet at home or be willing to use CONNECT in the clinic
- Must have access to telephone to complete sessions with the central caregiver navigator
Patient Exclusion Criteria:
- Patients who have completed treatment for their lung cancer at the time of study enrollment
- Enrolled in hospice care
- Unable to read and English and not willing to have someone read surveys for them
Caregiver Exclusion Criteria:
- Self-report currently receiving cancer treatment
- Unable to read and communicate in English, as the CONNECT intervention is currently only available in English
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Group 1 (Standard care followed by generic resource list)
Caregivers receive standard care and are then given a generic resource list at week 24. |
Receive a generic resource list |
|
Comparatore attivo: Group 2 (Generic resource list)
Caregiver receive a generic resource list at the start of the study. |
Receive a generic resource list |
|
Sperimentale: Group 3 (CONNECT, personalized list, and navigation)
Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs. |
Receive personalized resource list Receive access to CONNECT tool Complete calls with caregiver navigator
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Caregiver retention at 12 weeks
Lasso di tempo: At 12 weeks
|
Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval. |
At 12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Caregiver accrual rate
Lasso di tempo: Upon completion of recruitment, approximately 12 months
|
Number of caregivers who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver participation
Lasso di tempo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible caregivers who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver retention at 24 weeks
Lasso di tempo: At 24 weeks
|
Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized. |
At 24 weeks
|
|
Caregiver acceptability
Lasso di tempo: At 12 weeks
|
Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much) |
At 12 weeks
|
|
Average time (minutes) needed for training for Local Practice Referral Coordinator
Lasso di tempo: At completion of training, up to 6 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At completion of training, up to 6 months
|
|
Desired modality for training (e.g., live webinar, recorded video, paper materials) for Local Practice Referral Coordinator
Lasso di tempo: At completion of training, up to 6 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of training, up to 6 months
|
|
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
Lasso di tempo: At conclusion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At conclusion of practice intervention activities, an average of 18 months
|
|
Frequency of needed resource updates in the CONNECT database
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) spent by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modality of contact (e.g. phone, virtual web meeting, email) made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of contacts made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of referrals facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Type of referrals (e.g., in person, online) facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modalities used for communication (e.g., phone, virtual web meeting, email) for Central Caregiver Navigator and Local Practice Referral Coordinator
Lasso di tempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Improvements for the future trial from Local Practice Referral Coordinator's perspectives from a survey at the end of the study
Lasso di tempo: At completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of practice intervention activities, an average of 18 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Patient accrual rate
Lasso di tempo: Upon completion of recruitment, approximately 12 months
|
Number of patients who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Patient participation rate
Lasso di tempo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible patients who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Patient retention at 12 weeks
Lasso di tempo: At 12 weeks
|
Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized |
At 12 weeks
|
|
Patient retention at 24 weeks
Lasso di tempo: At 24 weeks
|
Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized |
At 24 weeks
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Cattedra di studio: Kathryn Weaver, PhD, Wake Forest University Health Sciences
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Neoplasie per sede
- Neoplasie
- Malattie delle vie respiratorie
- Malattie polmonari
- Neoplasie delle vie respiratorie
- Neoplasie toraciche
- Neoplasie polmonari
- Amministrazione dei servizi sanitari
- Terapie
- Cura del paziente
- Servizi sanitari
- Force di lavoro e servizi per le strutture sanitarie
- Gestione dell'assistenza al paziente
- Assistenza sanitaria globale
- Assistenza centrata sul paziente
- Assistenza sanitaria di base
- Cure palliative
- Navigazione del paziente
Altri numeri di identificazione dello studio
- IRB00112187
- NCI-2023-10870 (Altro identificatore: NCI Trial Identifier)
- Lead Organization Identifier (Altro identificatore: WF-2301CD)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.
Periodo di condivisione IPD
6 months after publication for a 2 year duration
Criteri di accesso alla condivisione IPD
upon request to NCORP@wakehealth.edu
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .